Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Ther ; 18(3): e78-80, 2011 May.
Article in English | MEDLINE | ID: mdl-20027103

ABSTRACT

Psoriasis is a papulosquamous disease of multifactorial etiology. A combination of genetic and environmental agents is implicated in its pathogenesis. A variety of triggers, including infection, stress, and medications, have been recognized as precipitants of this disease. Nonsteroidal anti-inflammatory drugs, beta-blockers, lithium, synthetic antimalarials, and gold are the most common drugs implicated in precipitating psoriasis. We report a patient with psoriasis induced by initiation of losartan therapy, which resolved with discontinuation of the drug. The Naranjo adverse drug reaction probability scale score indicated that the association between losartan use and psoriasis was probable.


Subject(s)
Angiotensin II Type 1 Receptor Blockers/adverse effects , Losartan/adverse effects , Psoriasis/diagnosis , Adrenergic beta-Antagonists/adverse effects , Adrenergic beta-Antagonists/pharmacology , Angiotensin II Type 1 Receptor Blockers/therapeutic use , Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Antimalarials/adverse effects , Antimalarials/pharmacology , Antimanic Agents/adverse effects , Antimanic Agents/pharmacology , Humans , Lithium/adverse effects , Losartan/therapeutic use , Male , Middle Aged , Psoriasis/chemically induced , Psoriasis/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...